CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Evrima Technologies
Australia
- Sydney, NSW
- 05/09/2022
- Unknown
- $3,000,000
Our vision is to be an innovative organisation that truly engages and enriches society through clinical trial awareness and participation. We are striving to make a global impact on overall clinical trial timelines and enable the industry to advance medical research swiftly.
Our mission is to automate the study start-up and patient recruitment processes using predictive technology to reduce inaccuracies, repetitive administrative headaches that study teams, sponsors and patients experience. Ultimately we want to have a direct impact on the overall time it takes for new and improved medicines to become available to those who need them.
- Industry Hospital & Health Care
- Website https://evrima.com.au/
- LinkedIn https://www.linkedin.com/company/evrimatechnologies/
Related People
Charlotte BradshawFounder
Australia -
ND
Experienced patient recruitment specialist with strong project management and digital marketing expertise across various therapeutic areas and trial phases. Client-focused and driven to achieve innovative solutions.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)